MitoQ protects against high glucose-induced brain microvascular endothelial cells injury via the Nrf2/HO-1 pathway
Brain microvascular endothelial cells (BMECs) dysfunction is related to the pathogenesis of neurovascular complication of diabetes mellitus that adversely lead to various CNS disorders. Mitoquinone (MitoQ) is a mitochondria targeted antioxidant that exerts multiple protective effects in many oxidati...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_25c25d24eb614c8082e1f05f6b0251ad | ||
042 | |a dc | ||
100 | 1 | 0 | |a Min-yan Yang |e author |
700 | 1 | 0 | |a Zhen Fan |e author |
700 | 1 | 0 | |a Zhao Zhang |e author |
700 | 1 | 0 | |a Jin Fan |e author |
245 | 0 | 0 | |a MitoQ protects against high glucose-induced brain microvascular endothelial cells injury via the Nrf2/HO-1 pathway |
260 | |b Elsevier, |c 2021-01-01T00:00:00Z. | ||
500 | |a 1347-8613 | ||
500 | |a 10.1016/j.jphs.2020.10.007 | ||
520 | |a Brain microvascular endothelial cells (BMECs) dysfunction is related to the pathogenesis of neurovascular complication of diabetes mellitus that adversely lead to various CNS disorders. Mitoquinone (MitoQ) is a mitochondria targeted antioxidant that exerts multiple protective effects in many oxidative damage-related diseases. In this study, we determined the protective effects of MitoQ on high glucose (HG)-induced BMECs injury and investigated the underlying mechanism. We found that HG significantly reduced the expression of Nrf2 and HO-1, decreased mitochondrial membrane potential, increased intracellular and mitochondrial reactive oxygen species (ROS) generation, induced cytoskeletal damage and apoptosis in BMECs. In addition, Mito tempol, a mitochondrial ROS scavenger, significantly reduced HG-induced mitochondrial ROS production and attenuated cytoskeletal damage and cell apoptosis, suggesting MtROS production was involved in HG-induced BMECs injury. Moreover, we found that MitoQ treatment significantly upregulated the expression of Nrf2 and HO-1 in HG-induced BMECs, which is accompanied by improved mitochondrial membrane potential and decreased MtROS production. Meanwhile, MitoQ treatment also remarkably attenuated HG-induced cytoskeletal damage and cell apoptosis in BMECs. However, inhibitor of Nrf2 with ML385 impaired the protective effects of MitoQ in HG-induced BMECs. In conclusion, our results suggest that MitoQ exerts protective effect on HG-induced BMECs injury via activating Nrf2/HO-1 pathway. | ||
546 | |a EN | ||
690 | |a MitoQ | ||
690 | |a Nrf2 | ||
690 | |a Mitochondrial ROS | ||
690 | |a Brain microvascular endothelial cells | ||
690 | |a Diabetes | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Journal of Pharmacological Sciences, Vol 145, Iss 1, Pp 105-114 (2021) | |
787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S1347861320301055 | |
787 | 0 | |n https://doaj.org/toc/1347-8613 | |
856 | 4 | 1 | |u https://doaj.org/article/25c25d24eb614c8082e1f05f6b0251ad |z Connect to this object online. |